Literature DB >> 30145857

[Spontaneous Bacterial Peritonitis].

Do Seon Song1.   

Abstract

Spontaneous bacterial peritonitis (SBP) is defined as bacterial infections that occur in patients with cirrhosis and ascites without any significant intraperitoneal infection, accounting for approximately 10-30% of bacterial infections in hospitalized patients. SBP develops in patients with liver cirrhosis because bacterial translocations are increased by changes in the intestinal bacteria and mucosal barriers. In addition, the decreased host immune response cannot remove the bacteria and their products. The most common cause of SBP is Gram-negative bacteria, such as Escherichia coli and Klebsiella species, and infections by Gram-positive bacteria are increasing. SBP is diagnosed by the presence of >250 polymorphonuclear leukocyte/mm3 in ascites after paracentesis. If SBP is diagnosed, empirical antibiotic therapy should be started immediately. Empirical antibiotic treatment should distinguish between community acquired infections and nosocomial infections. Cirrhotic patients with gastrointestinal bleeding or low ascitic protein concentrations should consider primary prevention and those who recover from SBP should consider secondary prevention. This review describes the pathophysiology, diagnosis, treatment, and prevention of SBP.

Entities:  

Keywords:  Ascites; Spontaneous bacterial peritonitis; Therapy

Mesh:

Substances:

Year:  2018        PMID: 30145857     DOI: 10.4166/kjg.2018.72.2.56

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  4 in total

1.  Initial choice of antibiotic in recurrent spontaneous bacterial peritonitis: A retrospective study.

Authors:  Gayathri Vasanthakumari Sasidharan Nair; Prannoy George Mathen; M Gopalakrishna Pillai; K P Gireesh Kumar; K K Velayudhan; T P Sreekrishnan
Journal:  Int J Crit Illn Inj Sci       Date:  2019-12-11

2.  Antibacterial Potential by Rupture Membrane and Antioxidant Capacity of Purified Phenolic Fractions of Persea americana Leaf Extract.

Authors:  Laura María Solís-Salas; Crystel Aleyvick Sierra-Rivera; Luis Enrique Cobos-Puc; Juan Alberto Ascacio-Valdés; Sonia Yesenia Silva-Belmares
Journal:  Antibiotics (Basel)       Date:  2021-04-29

3.  Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease.

Authors:  Hongmei Chen; Ye Zhang; Jie Zheng; Lei Shi; Yingli He; Yinghua Niu; Jine Lei; Yingren Zhao; Han Xia; Tianyan Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

4.  Alcoholic Liver Disease among Patients Admitted to the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Authors:  Ashlesha Chaudhary; Arun Kumar Chaudhary; Aashutosh Chaudhary; Abashesh Bhandari; Sujata Dahal; Suzit Bhusal
Journal:  JNMA J Nepal Med Assoc       Date:  2022-04-15       Impact factor: 0.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.